SCHEMBL44789

SCHEMBL44789

CCC=CCC(C(OC)OC)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.34
ALDH1A1 P00352 4/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
BCHE P06276 2/20 0.33
ADRA2B P18089 2/20 0.33
ADRA2C P18825 2/20 0.33
SLC6A2 P23975 2/20 0.33
HTR2A P28223 2/20 0.33
ADRA1A P35348 2/20 0.33
SLC6A3 Q01959 2/20 0.33
KCNH2 Q12809 2/20 0.33
SLC22A2 O15244 1/20 0.33
SLC22A1 O15245 1/20 0.33
SLC22A3 O75751 1/20 0.33
ESR1 P03372 1/20 0.33
CHRM2 P08172 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
ADORA3 P0DMS8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40135 1.00 TSHR (0.34) TSHRALDH1A1MAPK1SMN1; SMN2BCHE
SCHEMBL15070155 0.87 RCE1 (0.36) TSHRALDH1A1MAPK1SMN1; SMN2BCHE
SCHEMBL44573 0.82 SMN1; SMN2 (0.36) TSHRALDH1A1SMN1; SMN2ADRA2BADRA2C
SCHEMBL44025 0.81 TSHR (0.41) TSHRALDH1A1MAPK1SMN1; SMN2BCHE
SCHEMBL45416 0.79 SIGMAR1 (0.46) TSHRALDH1A1SMN1; SMN2ADRA2BADRA2C
SCHEMBL38834 0.73 BCHE (0.34) TSHRALDH1A1MAPK1SMN1; SMN2BCHE
SCHEMBL44484 0.73 CSNK1E (0.41) BCHEKCNH2SIGMAR1
SCHEMBL44989 0.71 SIGMAR1 (0.41) TSHRALDH1A1MAPK1SMN1; SMN2BCHE
SCHEMBL3331448 0.71 SIGMAR1 (0.44) TSHRALDH1A1MAPK1SMN1; SMN2BCHE
SCHEMBL15070151 0.70 SIGMAR1 (0.41) TSHRALDH1A1MAPK1SMN1; SMN2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9079824-B2 Method for the synthesis of an amino acetal NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2015-07-14 US disclosed
US-20130165682-A1 METHOD FOR THE SYNTHESIS OF AN AMINO ACETAL NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2013-06-27 US disclosed
WO-2012005693-A1 METHOD FOR THE SYNTHESIS OF AN AMINO ACETAL NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165682-A1 METHOD FOR THE SYNTHESIS OF AN AMINO ACETAL AOX1, DAO, ALDH7A1 TSHR 3830/4885ALDH1A1 11/4885MAPK1 3535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.